The frequency of previously undetectable deletions involving 3′ Exons of the PMS2 gene
- 25 September 2012
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 52 (1), 107-112
- https://doi.org/10.1002/gcc.22011
Abstract
Lynch syndrome is characterized by mutations in one of four mismatch repair genes, MLH1, MSH2, MSH6, or PMS2. Clinical mutation analysis of these genes includes sequencing of exonic regions and deletion/duplication analysis. However, detection of deletions and duplications in PMS2 has previously been confined to Exons 1–11 due to gene conversion between PMS2 and the pseudogene PMS2CL in the remaining 3′ exons (Exons 12–15). We have recently described an MLPA-based method that permits detection of deletions of PMS2 Exons 12–15; however, the frequency of such deletions has not yet been determined. To address this question, we tested for 3′ deletions in 58 samples that were reported to be negative for PMS2 mutations using previously available methods. All samples were from individuals whose tumors exhibited loss of PMS2 immunohistochemical staining without concomitant loss of MLH1 immunostaining. We identified seven samples in this cohort with deletions in the 3′ region of PMS2, including three previously reported samples with deletions of Exons 13–15 (two samples) and Exons 14–15. Also detected were deletions of Exons 12–15, Exon 13, and Exon 14 (two samples). Breakpoint analysis of the intragenic deletions suggests they occurred through Alu-mediated recombination. Our results indicate that ∼12% of samples suspected of harboring a PMS2 mutation based on immunohistochemical staining, for which mutations have not yet been identified, would benefit from testing using the new methodology.Keywords
This publication has 23 references indexed in Scilit:
- Clinical analysis ofPMS2: mutation detection and avoidance of pseudogenesHuman Mutation, 2010
- Quantification of sequence exchange events betweenPMS2andPMS2CLprovides a basis for improved mutation scanning of Lynch syndrome patientsHuman Mutation, 2010
- The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 MutationsGastroenterology, 2008
- Immunohistochemistry versus Microsatellite Instability Testing For Screening Colorectal Cancer Patients at Risk For Hereditary Nonpolyposis Colorectal Cancer Syndrome: Part I. The Utility of ImmunohistochemistryThe Journal of Molecular Diagnostics, 2008
- Café‐au‐lait macules and pediatric malignancy caused by biallelic mutations in the DNA mismatch repair (MMR) gene PMS2Pediatric Blood & Cancer, 2008
- Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1European Journal of Human Genetics, 2007
- Evolution of the Nomenclature for the Hereditary Colorectal Cancer SyndromesFamilial Cancer, 2005
- Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC)Genes, Chromosomes and Cancer, 2005
- Deletions Account for 17% of Pathogenic Germline Alterations in MLH1 and MSH2 in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) FamiliesGenetic Testing, 2005
- The Human Genome Browser at UCSCGenome Research, 2002